Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma Stage II”

995 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 995 results

Testing effectiveness (Phase 2)Study completedNCT01936532
What this trial is testing

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

Who this might be right for
Newly Diagnosed Multiple Myeloma
Nantes University Hospital 42
Early research (Phase 1)Study completedNCT00938626
What this trial is testing

Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 12
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Testing effectiveness (Phase 2)Study completedNCT00566098
What this trial is testing

Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Testing effectiveness (Phase 2)Study completedNCT01402284
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT01718743
What this trial is testing

Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Hematopoietic Cell Transplantation RecipientPlasma Cell Myeloma
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Testing effectiveness (Phase 2)Ended earlyNCT01248455
What this trial is testing

A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma

Who this might be right for
Multiple MyelomaMyelomaSmoldering Multiple Myeloma
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Ended earlyNCT01729338
What this trial is testing

Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Duke University 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04782687
What this trial is testing

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaMyeloma MultipleKahler Disease+4 more
US Oncology Research 73
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05909826
What this trial is testing

Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Dong-A University Hospital 49
Testing effectiveness (Phase 2)Study completedNCT00004158
What this trial is testing

Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Not applicableStudy completedNCT00898040
What this trial is testing

Study of DNA Samples From Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
ECOG-ACRIN Cancer Research Group 600
Testing effectiveness (Phase 2)Study completedNCT01313897
What this trial is testing

UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Testing effectiveness (Phase 2)Study completedNCT01037517
What this trial is testing

Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization

Who this might be right for
Multiple MyelomaLymphoma
CancerCare Manitoba 52
Testing effectiveness (Phase 2)Ended earlyNCT02353468
What this trial is testing

Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
Refractory Plasma Cell Myeloma
University of Colorado, Denver 3
Early research (Phase 1)Study completedNCT00310024
What this trial is testing

Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00616720
What this trial is testing

Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 15
Load More Results